KOREA WHO
-
-
-
Chairman of Dongkook Pharmaceutical
Kwon Gi-beom
Second-Generation Founder Became CEO at 34, Aiming for 'KRW 1 Trillion Total Healthcare Group'
-
Last Updated on Sep 23, 2024
-
Chairman of Dongkook Pharmaceutical
Life Summary
Kwon Gi-beom is the chairman of Dongkook Pharmaceutical.
Kwon is focusing on business expansion with the goal of achieving KRW 1 trillion (US$ 721.2 million) in revenue by 2025. He is particularly committed to strengthening the healthcare business and advancing the research and development of improved new drugs.
Born on March 23, 1967, Kwon Gi-beom is the eldest son of Kwon Dong-il, the founder of Dongkook Pharmaceutical.
He graduated from Yongsan High School in Seoul and went on to study social work (currently known as social welfare) at Yonsei University.
In 1991, he pursued an MBA at the University of Denver, and later completed the Stanford Executive Program in 1996 and the Trium Global EMBA in 2012.
Kwon joined Dongkook Pharmaceutical in 1994.
He held positions as managing director and executive director before being appointed vice president and CEO in 2002. He later served as president and vice chairman, eventually becoming chairman in 2022.
Taking on the CEO role at the young age of 34, Kwon grew Dongkook Pharmaceutical's revenue from around KRW 30 billion (US$ 21.6 million) in 2002 to KRW 730 billion (US$ 526.3 million) by 2023.
#KwonGibeom #DongkookPharmaceutical #pharmaceuticalindustry #businessgrowth #healthcare #newdrugdevelopment #executiveleadership #Koreanbusiness #corporateleadership #revenuegrowth
Kwon is focusing on business expansion with the goal of achieving KRW 1 trillion (US$ 721.2 million) in revenue by 2025. He is particularly committed to strengthening the healthcare business and advancing the research and development of improved new drugs.
Born on March 23, 1967, Kwon Gi-beom is the eldest son of Kwon Dong-il, the founder of Dongkook Pharmaceutical.
He graduated from Yongsan High School in Seoul and went on to study social work (currently known as social welfare) at Yonsei University.
In 1991, he pursued an MBA at the University of Denver, and later completed the Stanford Executive Program in 1996 and the Trium Global EMBA in 2012.
Kwon joined Dongkook Pharmaceutical in 1994.
He held positions as managing director and executive director before being appointed vice president and CEO in 2002. He later served as president and vice chairman, eventually becoming chairman in 2022.
Taking on the CEO role at the young age of 34, Kwon grew Dongkook Pharmaceutical's revenue from around KRW 30 billion (US$ 21.6 million) in 2002 to KRW 730 billion (US$ 526.3 million) by 2023.
#KwonGibeom #DongkookPharmaceutical #pharmaceuticalindustry #businessgrowth #healthcare #newdrugdevelopment #executiveleadership #Koreanbusiness #corporateleadership #revenuegrowth